Collaboration brings the next generation of cutting-edge ECG technology to trial participants' homes, enabling accurate cardiac safety trial measurements with fewer site visits. Clario and AliveCor ...

Thermo Fisher Scientific (NYSE:TMO) has confirmed a deal to acquire clinical trial data management firm Clario Holdings from a shareholder group led by Astorg and Nordic Capital, Novo Holding, and ...

PHILADELPHIA, April 16, 2025 /PRNewswire/ -- Clario, a leading provider of endpoint data solutions to the clinical trial industry, today announced a multi-year agreement with Amazon Web Services (AWS) ...

Healthcare technology provider Clario expanded its collaboration with AliveCor to use the electrocardiogram company's app to improve data collection in decentralized and hybrid clinical trials. Under ...

Notably, Clario centralizes clinical trial endpoint data from devices, sites and patients, allowing pharma and biotech companies to digitally collect, manage, and analyze evidence across all phases of ...

Thermo Fisher Scientific has reached a definitive agreement to acquire clinical trial endpoint data solutions provider Clario Holdings for $8.875bn in cash upon completion of the deal. Clario will be ...

PHILADELPHIA, March 10, 2025 /PRNewswire/ -- Clario, a leading provider of endpoint data solutions to the clinical trial industry, today announced they have entered into a definitive agreement to ...

Headquartered in Princeton, New Jersey, WCG is a provider of solutions that measurably improve and accelerate clinical research Dr. Chris Fikry serves as CEO of Clario and Sam Srivastava serves as CEO ...

This collaboration offers an end-to-end solution that allows sites to be supplied and trained on ophthalmic medical imaging equipment using Clario's manufacturer-agnostic ophthalmic software platform.